Interstitial Lung Disease
306
74
82
112
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
25 trials with published results (8%)
Research Maturity
112 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.2%
16 terminated out of 306 trials
87.5%
+1.0% vs benchmark
9%
27 trials in Phase 3/4
22%
25 of 112 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 112 completed trials
Clinical Trials (306)
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening Symptoms
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD
Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal Study
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Interstitial Lung Disease Research Unit Biobank
Evaluation of the Effectiveness, Safety, and Cost of a Smart Home-based Hospital System for Patients With Interstitial Lung Disease: Prospective Multicenter Randomized Controlled Trial
Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Aerobic Exercise in Patients With Pulmonary Hypertension
A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia